Factory 99% Potassium Clavulanate Powder CAS 61177-45-5 Antibiotic Chemical Intermediate

• Customization: Available
• Powder: Yes
• Customized: Customized
• Model NO.: A571
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Children, Adult
• State: Powder
• Purity: >99%
• Name: Potassium Clavulanate
• CAS: 61177-45-5
• Appearance: White Powder
• Assay: 99%
• OEM: Available
• Sample: Available
• Suitable: Adult
• MOQ: 10g
• Function: Antibiotic
• Transport Package: Foil Bag
• Specification: 99
• Trademark: /
• Origin: China
• Production Capacity: 10000 Kgs Per Month

Product Description

Product Name	Potassium Clavulanate
Appearance	White Powder
CAS NO.	61177-45-5
MF	C8H8KNO5
Storage	Keep in a cool, dry, dark location

 

Potassium clavulanate, is a β-lactamase inhibitor derived from clavulanic acid. It is a white or slightly yellow crystalline powder with a slight odor and a high tendency to absorb moisture. Potassium clavulanate is highly soluble in water, slightly soluble in ethanol, and insoluble in ether.

 

1. Pharmaceutical Industry: Potassium clavulanate is widely used in the pharmaceutical industry as a key component in combination antibiotics, particularly in formulations with amoxicillin.
2. Antibiotic Formulations: It is combined with other antibiotics to broaden their spectrum of activity and enhance their effectiveness against bacteria that produce β-lactamases.
3. Veterinary Medicine: It also finds application in veterinary medicine for treating bacterial infections in animals.

1. β-Lactamase Inhibition: Potassium clavulanate functions by inhibiting β-lactamases, an enzyme produced by some bacteria that can inactivate β-lactam antibiotics like penicillin and cephalosporins.
2. Antibacterial Synergy: When combined with β-lactam antibiotics, it allows the antibiotics to remain active and effective against bacteria that would otherwise be resistant due to β-lactamase production.
3. Enhanced Antibiotic Therapy: By inhibiting β-lactamases, potassium clavulanate enhances the therapeutic efficacy of β-lactam antibiotics, leading to improved patient outcomes in the treatment of bacterial infections.